Insights on the Single Cell Sequencing Global Market to 2027 – Ongoing Demand for Personalized or Customized Medicine Presents Opportunities –

DUBLIN–(BUSINESS WIRE)–The “Single Cell Sequencing Market Research Report by Product (Consumables and Instruments), Application, End-User, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) – Global Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to’s offering.

The Global Single Cell Sequencing Market size was estimated at USD 2,301.59 million in 2021, USD 2,407.37 million in 2022, and is projected to grow at a Compound Annual Growth Rate (CAGR) of 4.77% to reach USD 3,044.54 million by 2027.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Single Cell Sequencing Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Single Cell Sequencing Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Single Cell Sequencing Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Single Cell Sequencing Market?

4. What is the competitive strategic window for opportunities in the Global Single Cell Sequencing Market?

5. What are the technology trends and regulatory frameworks in the Global Single Cell Sequencing Market?

6. What is the market share of the leading vendors in the Global Single Cell Sequencing Market?

7. What modes and strategic moves are considered suitable for entering the Global Single Cell Sequencing Market?

Market Dynamics


  • Growing government funding and public-private collaborations for research activities
  • Rising number of pharmaceutical and biotechnology companies
  • Increasing prevalence of chronic and infectious diseases


  • Increasing prevalence of chronic and infectious diseases


  • Ongoing demand for personalized or customized medicine
  • Rising potential of single-cell sequencing and stem cell research


  • Difficulty in the measurement of single DNA molecule

Companies Mentioned

  • 10x Genomics, Inc.
  • Agilent Technologies, Inc.
  • Becton, Dickinson, and Company
  • BGI Genomics Co. Ltd.
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • DNA Electronics Ltd.
  • F. Hoffmann-La Roche Ltd
  • Fluidigm Corporation
  • Fluxion Biosciences
  • General Electric Company
  • Illumina, Inc.
  • Johnson & Johnson
  • Lumacyte
  • Luminex Corporation
  • Menarini Silicon Biosystems
  • Merck Millipore
  • Mission Bio
  • NanoString Technologies, Inc.
  • Oxford Nanopore Technologies
  • PerkinElmer, Inc.
  • Promega Corporation
  • Qiagen N.V.
  • Sartorius AG
  • Takara Bio, Inc.
  • Tecan Group Ltd.
  • Thermo Fisher Scientific, Inc.
  • Zephyrus Biosciences Inc.

For more information about this report visit


Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900